NRXC.F Stock Overview
Develops and markets nutraceutical products in Canada, Germany, and Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NeutriSci International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.000001 |
| 52 Week High | CA$0.009 |
| 52 Week Low | CA$0.000001 |
| Beta | 0.80 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NRXC.F | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 4.3% | 2.2% |
| 1Y | n/a | -12.0% | 31.6% |
Return vs Industry: Insufficient data to determine how NRXC.F performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how NRXC.F performed against the US Market.
Price Volatility
| NRXC.F volatility | |
|---|---|
| NRXC.F Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NRXC.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NRXC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Glen Rehman | www.neutrisci.com |
NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets.
NeutriSci International Inc. Fundamentals Summary
| NRXC.F fundamental statistics | |
|---|---|
| Market cap | US$639.60k |
| Earnings (TTM) | -US$552.45k |
| Revenue (TTM) | US$59.98k |
0.0x
P/S Ratio0.0x
P/E RatioIs NRXC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NRXC.F income statement (TTM) | |
|---|---|
| Revenue | CA$59.98k |
| Cost of Revenue | CA$145.85k |
| Gross Profit | -CA$85.86k |
| Other Expenses | CA$466.59k |
| Earnings | -CA$552.45k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0031 |
| Gross Margin | -143.15% |
| Net Profit Margin | -921.00% |
| Debt/Equity Ratio | -23.2% |
How did NRXC.F perform over the long term?
See historical performance and comparison